Search research articles
Contact Us
Filters
Showing results (51-60 of 87) with videos related to
Page
of 9
Sort By:
Japanese Journal of Clinical Oncology
|
May 5, 2019
A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients
Tomoko Iehara, Shigeki Yagyu, Takahiro Gotoh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2012
Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
Tomoko Iehara, Eiso Hiyama, Tatsuro Tajiri, et al.
European Journal of Haematology
|
May 7, 2005
Successful non-T-cell-depleted HLA-haploidentical 3-loci mismatched bone marrow transplantation
Shigeki Yagyu, Hiroshi Kuroda, Atsushi Fujiki, et al.
International Journal of Hematology
|
January 31, 2006
A novel perforin gene mutation in a Japanese family with hemophagocytic lymphohistiocytosis
Ikuyo Ueda, Urara Kohdera, Shigeyoshi Hibi, et al.
Haematologica
|
November 21, 2007
Association of transforming growth factor-beta1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases
Kanako Hatta, Akira Morimoto, Eiichi Ishii, et al.
Molecular Brain
|
June 23, 2009
Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice
Koichi Tanda, Akinori Nishi, Naoki Matsuo, et al.
International Journal of Clinical Oncology
|
March 3, 2012
Successful treatment of infants with localized neuroblastoma based on their MYCN status
Tomoko Iehara, Minoru Hamazaki, Tatsuro Tajiri, et al.
Biochemical and Biophysical Research Communications
|
May 8, 2007
Induction of apoptosis by an inhibitor of EGFR in neuroblastoma cells
Shinichi Tamura, Hajime Hosoi, Yasumichi Kuwahara, et al.
Cancer Letters
|
April 14, 2011
Identification of therapy-sensitive and therapy-resistant neuroblastoma subtypes in stages III, IVs and IV
Yohko Kyo, Takeo Tanaka, Kunihiko Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction
Takahiro Gotoh, Hajime Hosoi, Tomoko Iehara, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 87) with videos related to
Sort By:
Page
of 9
Japanese Journal of Clinical Oncology
|
May 5, 2019
A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients
Tomoko Iehara, Shigeki Yagyu, Takahiro Gotoh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2012
Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
Tomoko Iehara, Eiso Hiyama, Tatsuro Tajiri, et al.
European Journal of Haematology
|
May 7, 2005
Successful non-T-cell-depleted HLA-haploidentical 3-loci mismatched bone marrow transplantation
Shigeki Yagyu, Hiroshi Kuroda, Atsushi Fujiki, et al.
International Journal of Hematology
|
January 31, 2006
A novel perforin gene mutation in a Japanese family with hemophagocytic lymphohistiocytosis
Ikuyo Ueda, Urara Kohdera, Shigeyoshi Hibi, et al.
Haematologica
|
November 21, 2007
Association of transforming growth factor-beta1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases
Kanako Hatta, Akira Morimoto, Eiichi Ishii, et al.
Molecular Brain
|
June 23, 2009
Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice
Koichi Tanda, Akinori Nishi, Naoki Matsuo, et al.
International Journal of Clinical Oncology
|
March 3, 2012
Successful treatment of infants with localized neuroblastoma based on their MYCN status
Tomoko Iehara, Minoru Hamazaki, Tatsuro Tajiri, et al.
Biochemical and Biophysical Research Communications
|
May 8, 2007
Induction of apoptosis by an inhibitor of EGFR in neuroblastoma cells
Shinichi Tamura, Hajime Hosoi, Yasumichi Kuwahara, et al.
Cancer Letters
|
April 14, 2011
Identification of therapy-sensitive and therapy-resistant neuroblastoma subtypes in stages III, IVs and IV
Yohko Kyo, Takeo Tanaka, Kunihiko Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction
Takahiro Gotoh, Hajime Hosoi, Tomoko Iehara, et al.
Page
of 9